Selank vs Semax

Overview

Selank is a synthetic heptapeptide analog of the endogenous immunomodulatory peptide tuftsin. It has been studied extensively for anxiolytic (anti-anxiety) effects and as a cognitive enhancer, with particular interest in its ability to regulate BDNF (brain-derived neurotrophic factor) and modulate the GABAergic system. Semax is a synthetic analog of ACTH (adrenocorticotropic hormone) that has been approved as a pharmaceutical in Russia for conditions including stroke, optic nerve atrophy, and cognitive impairment. It shows strong nootropic and neuroprotective effects in preclinical and clinical research.

Mechanism of Action

Selank is thought to produce its anxiolytic effects primarily through modulation of the GABAergic system and by increasing brain serotonin metabolism. It also upregulates BDNF expression, which supports neuronal survival and synaptic plasticity. Semax operates differently — it binds to melanocortin receptors and increases the expression of BDNF and its receptor TrkB, while also modulating dopaminergic and serotonergic systems. Its ACTH-like sequence gives it additional neuroprotective properties not shared by Selank.

Cognitive Benefits

Selank

Placeholder — documented cognitive effects including improved memory consolidation, enhanced attention, and learning facilitation will be detailed here with linked citations from Russian and international research literature.

Semax

Placeholder — documented nootropic effects including enhanced focus, improved working memory, neuroprotection after ischemic events, and BDNF upregulation will be detailed here with linked citations including clinical trial data.

Anxiety & Mood

Selank has a stronger and more direct anxiolytic profile of the two. Its GABAergic modulation produces calming effects that have been compared to benzodiazepines in some research contexts, but without the sedation, dependence risk, or cognitive impairment associated with that drug class. Semax can have mild stimulating properties that some users report as energizing, but it does not target anxiety as a primary endpoint. For individuals dealing primarily with anxiety or stress, Selank is generally considered the more appropriate choice.

Mood Effects (Placeholder)

A deeper comparison of mood-related effects, including data on depression, emotional regulation, and stress resilience, will be added here.

Side Effects

Both peptides have demonstrated favorable safety profiles in the existing research, which is considerable for Semax given its approved pharmaceutical status in Russia. Selank's most commonly reported effects are mild sedation at higher doses and occasional transient fatigue. Semax side effects are generally mild and may include irritability, mild blood pressure changes, or nasal irritation when administered intranasally. Neither compound is approved by the FDA for human therapeutic use outside of clinical trials.

Contraindications (Placeholder)

Population-specific considerations, drug interactions, and contraindications will be documented here. This page does not constitute medical advice.

Which Should You Choose?

Choose Selank if your primary goal is anxiety reduction, stress management, or calm and focused cognition. Its anxiolytic mechanism makes it especially well-suited for high-stress periods or situations requiring composed, clear thinking.

Choose Semax if your primary goal is cognitive performance, memory enhancement, or neuroprotection. Its more activating profile and stronger BDNF upregulation make it a better fit for cognitive work and long-term brain health applications.

Some researchers use both compounds, alternating or combining them based on the context. Placeholder — protocol guidance and cycling considerations will be added here.